Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas.

about

Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas.

Item

http://www.wikidata.org/entity/Q55316951

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@en

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@nl

type

Item

label

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@en

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@nl

prefLabel

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@en

Platelet-derived growth factor ...... m cell phenotypes in sarcomas.

@nl

P1476

Platelet-derived growth factor ...... em cell phenotypes in sarcomas

@en

P2093

Brendan C Yi

http://www.w3.org/2001/XMLSchema#string

Changhwan Yoon

http://www.w3.org/2001/XMLSchema#string

M Celeste Simon

http://www.w3.org/2001/XMLSchema#string

Sam S Yoon

http://www.w3.org/2001/XMLSchema#string

William D Tap

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of epithelial-mesenchymal transition

Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.

Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Targeting the PDGF signaling pathway in tumor treatment

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Mesenchymal stem cell transformation and sarcoma genesis.

Hypoxia-inducible factors in cancer stem cells and inflammation.

The cancer stem cell hypothesis: a work in progress.

P2888

s41389-018-0059-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41389-018-0059-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kevin K Chang

P577

2018-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104611780

http://www.w3.org/2001/XMLSchema#string

P698

29915281

http://www.w3.org/2001/XMLSchema#string

P932

6006341

http://www.w3.org/2001/XMLSchema#string